Lifeboat Foundation

Opening RemarksAugust 19, 2024

Amid ongoing human clinical trials, there is still a long way to go before neural chips are commonplace in clinics.

Neuroscientists at Stanford have linked Alzheimer’s disease to the disruption of brain metabolism via the kynurenine pathway, which is affected by amyloid plaque and tau proteins.

Their research has demonstrated that drugs blocking this pathway can restore cognitive function in Alzheimer’s mice by improving brain metabolism. This discovery not only bridges the gap between neuroscience and oncology but also provides a fast track to repurposing existing drugs for Alzheimer’s treatment.

Alzheimer’s disease and brain energy metabolism.

With investments, approvals, and revenues on the rise, gene editing therapy is increasingly able to address delivery and accessibility challenges.

An iterative engineering approach to improve prime editor delivery helped scientists correct genetic vision defects in mice.

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

Summary: Researchers have identified a link between brain overgrowth and the severity of social and communication symptoms in children with autism spectrum disorder (ASD).

By analyzing MRI scans and conducting experiments with brain organoids, the study found that children with the most severe ASD symptoms had significantly larger brains. This enlargement is associated with altered activity of the enzyme Ndel1, which plays a crucial role in neuron development.

The findings open new avenues for understanding ASD and its varying symptom severity.

Engineers have developed the world’s first quantum microprocessor chip for simulating large and complex molecular structures.

What happens when we’re faced with something no one has ever seen before – a disruptive force that has no clear historical precedent? Something like artificial general intelligence (AGI).